The global lung cancer screening software market refers to the industry developing software tools that assist in early detection of lung cancer using medical imaging, especially low-dose CT scans. These solutions use AI and analytics to identify nodules, support diagnosis, and improve screening efficiency in healthcare facilities. Lung cancer screening software is a medical software solution designed to analyze imaging data, especially low-dose CT scans, to help detect lung nodules and early signs of lung cancer. It uses technologies such as artificial intelligence and computer-aided detection to assist radiologists in diagnosis, risk assessment, and patient screening management. In December 2025, AZmed launched AZnod, an AI-powered CT analysis tool under the Rayscan product line after receiving CE marking. The solution detects and characterizes lung nodules between 3–30 mm on CT scans, delivering standardized measurements and structured reports to support lung cancer screening programs and radiologists. In 2025, Coreline Soft partnered with Oatmeal Health to jointly develop an AI-based lung cancer screening solution combining nodule detection and malignancy prediction. The collaboration targets the U.S. market, seeking FDA clearance and expansion within the estimated $1.6 billion annual screening market. In February 2025, The Lung Cancer Screening and Prevention Act of 2025 (H.R. 1406) was introduced to expand Medicare coverage for additional FDA-approved lung cancer screening tests. The bill directs Centers for Medicare & Medicaid Services to set payment limits, potentially supporting adoption of innovative AI-based screening software tools
This comprehensive market research report provides an in-depth analysis of the Global Lung Cancer Screening Software Market market, with a focused evaluation of industry developments through 2025. The study delivers detailed insights into current market dynamics, emerging trends, growth drivers, competitive landscape, future strategic outlook, and the evolving regulatory key segments.
The Global Global Lung Cancer Screening Software Market Market Report identifies emerging business opportunities while supporting informed strategic and tactical decision-making. Designed for stakeholders operating in a highly competitive and rapidly evolving landscape, this study delivers up-to-date market intelligence essential for tracking performance, mitigating risks, and driving sustainable growth and profitability.
Our expert team is consistently working on updated data and information on the key player's related business processes that value the market for future strategies and predictions
Get Access to a Free Copy of Our Latest Sample Report - https://www.decisionsadvisors.com/request-sample/DAR4696
Key Insights Covered in the Global Global Lung Cancer Screening Software Market Market Size & Industry Forecast Report (2020–2035):
1. Detailed analysis of the Global Global Lung Cancer Screening Software Market Market Size, production capacity, utilization rate, output trends, capital investment patterns, and regulatory landscape, along with comprehensive profiles of leading market players.
2. Thorough assessment of Global Lung Cancer Screening Software Market Market Growth, revenue analysis, historical performance, and forward-looking projections across major regional markets.
3. In-depth Global Lung Cancer Screening Software Market Industry Analysis covering competitive landscape, company market share, pricing trends, and future opportunity mapping.
4. Strategic evaluation of recent developments including mergers & acquisitions, partnerships, collaborations, joint ventures, geographic expansions, and product launches shaping the Global Lung Cancer Screening Software Market Market Share.
5. Comprehensive value chain and supply chain analysis highlighting raw material sourcing, distribution channels, and end-user segmentation.
6. Regional regulatory framework assessment and policy impact analysis influencing the Global Lung Cancer Screening Software Market Industry Forecast across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
7. Coverage of technological advancements, product innovations, R&D investments, automation trends, and digital transformation influencing long-term Global Global Lung Cancer Screening Software Market Market Growth.
Buy this report now:- https://www.decisionsadvisors.com/checkout/select-licence?report_id=DAR4696
Uses of Lung Cancer Screening Software
Early Lung Cancer Detection
The software helps identify lung cancer during its earliest stages, improving treatment success rates and patient survival.
Pulmonary Nodule Monitoring
Healthcare providers use the software to monitor lung nodules over time and assess malignancy risk.
Large-Scale Screening Programs
Governments and healthcare organizations utilize screening software to manage national and regional lung cancer screening initiatives.
Clinical Decision Support
AI-powered insights assist radiologists and oncologists in diagnosis, treatment planning, and follow-up care.
Medical Research and Imaging Studies
Research institutions use advanced screening software for clinical trials, imaging analysis, and AI development.
Advantages of the Global Lung Cancer Screening Software Market
Improved Diagnostic Accuracy
AI-enabled screening systems enhance detection accuracy and help identify abnormalities that may be overlooked during manual analysis.
Faster Screening and Reporting
Automation significantly reduces scan interpretation time and increases radiology department efficiency.
Reduced Radiologist Workload
AI-assisted tools help radiologists prioritize suspicious cases and manage growing imaging volumes more effectively.
Better Patient Outcomes
Early detection enables timely treatment, leading to improved survival rates and reduced healthcare costs.
Enhanced Screening Program Efficiency
Integrated workflow management systems simplify patient scheduling, follow-up tracking, and reporting processes.
Regional Analysis for Global Lung Cancer Screening Software Market Market:
✫ North America: (U.S., Canada, Mexico)
✫ Europe: (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
✫ Asia-Pacific: (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
✫ South America: (Colombia, Brazil, Argentina, Rest of South America)
✫ Middle East & Africa: (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Benefits of the Report:
⏩ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.
⏩ Top-down and bottom-up approach for regional analysis
⏩ Porter’s five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.
⏩ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market
Insightful inquiry before buying:- https://www.decisionsadvisors.com/request-customization/DAR4696
Frequently asked questions:
➥ What is the market size of the Global Lung Cancer Screening Software Market market?
➥ What is the market growth rate of the Global Lung Cancer Screening Software Market market?
➥ What are the Global Lung Cancer Screening Software Market market opportunities and threats faced by the vendors in the global Global Lung Cancer Screening Software Market Industry?
➥ Which application/end-user or product type may seek incremental growth prospects? What is the market share of each type and application?
➥ What focused approach and constraints are holding the Global Lung Cancer Screening Software Market market?
➥ What are the different sales, marketing, and distribution channels in the global industry?
Unlock the full report now! @ https://www.decisionsadvisors.com/reports/lung-cancer-screening-software-market
About the Decisions Advisors
Decisions Advisors is a comprehensive market research and consulting company that provides actionable insights based on data. We deal with businesses from various industries and deliver a market intelligence, competitive analysis, forecasting, and bespoke consulting. We also conduct bespoke consulting for our clients.
We provides well-supported advice and intelligence on how businesses can operate in a given market and succeed in achieving their goals.
Contact Us:
Company Name: Decision Advisors
Email: [email protected]
Phone: +1 303 800 4326 (US)
Follow Us: LinkedIn | Facebook | Twitter